Literature DB >> 33545734

[Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers].

Andreas Stallmach1, Andreas Sturm2, Irina Blumenstein3, Ulf Helwig4, Sibylle Koletzko5, Petra Lynen6, Carsten Schmidt7, Axel Dignaß8, Torsten Kucharzik9.   

Abstract

Entities:  

Year:  2021        PMID： 33545734     DOI： 10.1055/a-1375-6282

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN： 0044-2771            Impact factor:   2.000


× No keyword cloud information.
  1 in total

1.  Antibody response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease - results of a single-center cohort study in a tertiary hospital in Germany.

Authors:  Johanna Maria Classen; Anna Muzalyova; Sandra Nagl; Carola Fleischmann; Alanna Ebigbo; Christoph Römmele; Helmut Messmann; Elisabeth Schnoy
Journal:  Dig Dis       Date:  2021-12-10       Impact factor: 2.404
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.